Literature DB >> 18533278

Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the kappa-opioid receptor.

Matthew J Finley1, Xiaohong Chen, Guiseppe Bardi, Penny Davey, Ellen B Geller, Lily Zhang, Martin W Adler, Thomas J Rogers.   

Abstract

We previously characterized multiple interactions between chemokine and opioid G protein-coupled receptors (GPCR), and we found both mu and delta-opioid receptors cross-desensitize CCR1, CCR2, CCR5, but not CXCR4. Here we report that the kappa-opioid receptor (KOR) is able to cross-desensitize CXCR4, and this phenomenon is bi-directional. Chemotactic responses by KOR activation are diminished with prior activation of CXCR4. Additionally, calcium mobilization assays show these cross-desensitization processes occur within seconds of receptor activation, and target receptor internalization is not responsible for desensitization between these receptors. These results have implications for several essential processes including neuronal and lymphocyte development, inflammatory responses, and pain/sensitivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18533278      PMCID: PMC2596309          DOI: 10.1016/j.jneuroim.2008.04.021

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  67 in total

Review 1.  Chemokine receptors: signposts to brain development and disease.

Authors:  Phuong B Tran; Richard J Miller
Journal:  Nat Rev Neurosci       Date:  2003-06       Impact factor: 34.870

Review 2.  The bicyclam AMD3100 story.

Authors:  Erik De Clercq
Journal:  Nat Rev Drug Discov       Date:  2003-07       Impact factor: 84.694

3.  Sequence of kappa-opioid receptor cDNA in the R1.1 thymoma cell line.

Authors:  S M Belkowski; J Zhu; L Y Liu-Chen; T K Eisenstein; M W Adler; T J Rogers
Journal:  J Neuroimmunol       Date:  1995-10       Impact factor: 3.478

4.  Complementary DNA cloning of a mu-opioid receptor from rat peritoneal macrophages.

Authors:  M Sedqi; S Roy; S Ramakrishnan; R Elde; H H Loh
Journal:  Biochem Biophys Res Commun       Date:  1995-04-17       Impact factor: 3.575

5.  Basal and inducible transcriptional activity of an upstream AP-1/CRE element (DYNCRE3) in the prodynorphin promoter.

Authors:  D J Messersmith; J Gu; R Dubner; J Douglass; M J Iadarola
Journal:  Mol Cell Neurosci       Date:  1994-06       Impact factor: 4.314

6.  Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication.

Authors:  Amber D Steele; Earl E Henderson; Thomas J Rogers
Journal:  Virology       Date:  2003-04-25       Impact factor: 3.616

7.  Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes.

Authors:  M Loetscher; T Geiser; T O'Reilly; R Zwahlen; M Baggiolini; B Moser
Journal:  J Biol Chem       Date:  1994-01-07       Impact factor: 5.157

8.  Inhibition of primary murine macrophage cytokine production in vitro following treatment with the kappa-opioid agonist U50,488H.

Authors:  C Alicea; S Belkowski; T K Eisenstein; M W Adler; T J Rogers
Journal:  J Neuroimmunol       Date:  1996-01       Impact factor: 3.478

9.  Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue.

Authors:  M Schäfer; L Carter; C Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

10.  Delta opioid receptor gene expression in lymphocytes.

Authors:  L F Chuang; T K Chuang; K F Killam; A J Chuang; H F Kung; L Yu; R Y Chuang
Journal:  Biochem Biophys Res Commun       Date:  1994-08-15       Impact factor: 3.575

View more
  33 in total

1.  Surgical management of apical pelvic support defects: the impact of robotic technology.

Authors:  Ashley W Carroll; Elizabeth Lamb; Audra Jo Hill; Edward J Gill; Catherine A Matthews
Journal:  Int Urogynecol J       Date:  2012-04-12       Impact factor: 2.894

Review 2.  Mechanisms regulating chemokine receptor activity.

Authors:  Laura D Bennett; James M Fox; Nathalie Signoret
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

Review 3.  Modulation of chemokine receptor activity through dimerization and crosstalk.

Authors:  C L Salanga; M O'Hayre; T Handel
Journal:  Cell Mol Life Sci       Date:  2009-04       Impact factor: 9.261

4.  Autoantibodies to the delta-opioid receptor function as opioid agonists and display immunomodulatory activity.

Authors:  Parvathi Ranganathan; Hao Chen; Miranda K Adelman; Samuel F Schluter
Journal:  J Neuroimmunol       Date:  2009-10-30       Impact factor: 3.478

5.  Neuronal ferritin heavy chain and drug abuse affect HIV-associated cognitive dysfunction.

Authors:  Jonathan Pitcher; Anna Abt; Jaclyn Myers; Rachel Han; Melissa Snyder; Alessandro Graziano; Lindsay Festa; Michele Kutzler; Fernando Garcia; Wen-Jun Gao; Tracy Fischer-Smith; Jay Rappaport; Olimpia Meucci
Journal:  J Clin Invest       Date:  2014-01-09       Impact factor: 14.808

Review 6.  Progress in elucidating the structural and dynamic character of G Protein-Coupled Receptor oligomers for use in drug discovery.

Authors:  A Bortolato; J C Mobarec; D Provasi; M Filizola
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

7.  Activation of cannabinoid type 2 receptors inhibits HIV-1 envelope glycoprotein gp120-induced synapse loss.

Authors:  Hee Jung Kim; Angela H Shin; Stanley A Thayer
Journal:  Mol Pharmacol       Date:  2011-06-13       Impact factor: 4.436

8.  Differential expression of the alternatively spliced OPRM1 isoform μ-opioid receptor-1K in HIV-infected individuals.

Authors:  Seth M Dever; Blair N Costin; Ruqiang Xu; Nazira El-Hage; Joyce Balinang; Alexander Samoshkin; Megan A O'Brien; Marypeace McRae; Luda Diatchenko; Pamela E Knapp; Kurt F Hauser
Journal:  AIDS       Date:  2014-01-02       Impact factor: 4.177

9.  Cross-desensitization of CCR1, but not CCR2, following activation of the formyl peptide receptor FPR1.

Authors:  Filip Bednar; Changcheng Song; Giuseppe Bardi; William Cornwell; Thomas J Rogers
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

10.  Pertussis toxin signals through the TCR to initiate cross-desensitization of the chemokine receptor CXCR4.

Authors:  Olivia D Schneider; Alison A Weiss; William E Miller
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.